Request for Covid-19 Impact Assessment of this Report
The United States Erectile Dysfunction Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Erectile Dysfunction Medicine market, reaching US$ million by the year 2028. As for the Europe Erectile Dysfunction Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Erectile Dysfunction Medicine players cover Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, and Bayer AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Erectile Dysfunction Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Viagra
Cialis
Levitra
Stendra
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Online Pharmacies
Retail Pharmacies
Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer, Inc.
Dong-A ST Co., Ltd.
Eli Lilly and Company
Bayer AG
Vivus, Inc.
Teva Pharmaceutical Industries Ltd.
SK Chemicals
Meda Pharmaceuticals, Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltda
Apricus Biosciences, Inc.
Futura Medical plc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Medicine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Erectile Dysfunction Medicine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Erectile Dysfunction Medicine by Country/Region, 2017, 2022 & 2028
2.2 Erectile Dysfunction Medicine Segment by Type
2.2.1 Viagra
2.2.2 Cialis
2.2.3 Levitra
2.2.4 Stendra
2.3 Erectile Dysfunction Medicine Sales by Type
2.3.1 Global Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
2.3.2 Global Erectile Dysfunction Medicine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Erectile Dysfunction Medicine Sale Price by Type (2017-2022)
2.4 Erectile Dysfunction Medicine Segment by Distribution Channel
2.4.1 Online Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Hospital
2.5 Erectile Dysfunction Medicine Sales by Distribution Channel
2.5.1 Global Erectile Dysfunction Medicine Sale Market Share by Distribution Channel (2017-2022)
2.5.2 Global Erectile Dysfunction Medicine Revenue and Market Share by Distribution Channel (2017-2022)
2.5.3 Global Erectile Dysfunction Medicine Sale Price by Distribution Channel (2017-2022)
3 Global Erectile Dysfunction Medicine by Company
3.1 Global Erectile Dysfunction Medicine Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Medicine Annual Sales by Company (2020-2022)
3.1.2 Global Erectile Dysfunction Medicine Sales Market Share by Company (2020-2022)
3.2 Global Erectile Dysfunction Medicine Annual Revenue by Company (2020-2022)
3.2.1 Global Erectile Dysfunction Medicine Revenue by Company (2020-2022)
3.2.2 Global Erectile Dysfunction Medicine Revenue Market Share by Company (2020-2022)
3.3 Global Erectile Dysfunction Medicine Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Medicine Product Location Distribution
3.4.2 Players Erectile Dysfunction Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Erectile Dysfunction Medicine by Geographic Region
4.1 World Historic Erectile Dysfunction Medicine Market Size by Geographic Region (2017-2022)
4.1.1 Global Erectile Dysfunction Medicine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Erectile Dysfunction Medicine Annual Revenue by Geographic Region
4.2 World Historic Erectile Dysfunction Medicine Market Size by Country/Region (2017-2022)
4.2.1 Global Erectile Dysfunction Medicine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Erectile Dysfunction Medicine Annual Revenue by Country/Region
4.3 Americas Erectile Dysfunction Medicine Sales Growth
4.4 APAC Erectile Dysfunction Medicine Sales Growth
4.5 Europe Erectile Dysfunction Medicine Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Medicine Sales Growth
5 Americas
5.1 Americas Erectile Dysfunction Medicine Sales by Country
5.1.1 Americas Erectile Dysfunction Medicine Sales by Country (2017-2022)
5.1.2 Americas Erectile Dysfunction Medicine Revenue by Country (2017-2022)
5.2 Americas Erectile Dysfunction Medicine Sales by Type
5.3 Americas Erectile Dysfunction Medicine Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Medicine Sales by Region
6.1.1 APAC Erectile Dysfunction Medicine Sales by Region (2017-2022)
6.1.2 APAC Erectile Dysfunction Medicine Revenue by Region (2017-2022)
6.2 APAC Erectile Dysfunction Medicine Sales by Type
6.3 APAC Erectile Dysfunction Medicine Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erectile Dysfunction Medicine by Country
7.1.1 Europe Erectile Dysfunction Medicine Sales by Country (2017-2022)
7.1.2 Europe Erectile Dysfunction Medicine Revenue by Country (2017-2022)
7.2 Europe Erectile Dysfunction Medicine Sales by Type
7.3 Europe Erectile Dysfunction Medicine Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erectile Dysfunction Medicine by Country
8.1.1 Middle East & Africa Erectile Dysfunction Medicine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Erectile Dysfunction Medicine Revenue by Country (2017-2022)
8.2 Middle East & Africa Erectile Dysfunction Medicine Sales by Type
8.3 Middle East & Africa Erectile Dysfunction Medicine Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction Medicine
10.3 Manufacturing Process Analysis of Erectile Dysfunction Medicine
10.4 Industry Chain Structure of Erectile Dysfunction Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Medicine Distributors
11.3 Erectile Dysfunction Medicine Customer
12 World Forecast Review for Erectile Dysfunction Medicine by Geographic Region
12.1 Global Erectile Dysfunction Medicine Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Medicine Forecast by Region (2023-2028)
12.1.2 Global Erectile Dysfunction Medicine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Erectile Dysfunction Medicine Forecast by Type
12.7 Global Erectile Dysfunction Medicine Forecast by Distribution Channel
13 Key Players Analysis
13.1 Pfizer, Inc.
13.1.1 Pfizer, Inc. Company Information
13.1.2 Pfizer, Inc. Erectile Dysfunction Medicine Product Offered
13.1.3 Pfizer, Inc. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer, Inc. Main Business Overview
13.1.5 Pfizer, Inc. Latest Developments
13.2 Dong-A ST Co., Ltd.
13.2.1 Dong-A ST Co., Ltd. Company Information
13.2.2 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product Offered
13.2.3 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Dong-A ST Co., Ltd. Main Business Overview
13.2.5 Dong-A ST Co., Ltd. Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Erectile Dysfunction Medicine Product Offered
13.3.3 Eli Lilly and Company Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Erectile Dysfunction Medicine Product Offered
13.4.3 Bayer AG Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 Vivus, Inc.
13.5.1 Vivus, Inc. Company Information
13.5.2 Vivus, Inc. Erectile Dysfunction Medicine Product Offered
13.5.3 Vivus, Inc. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Vivus, Inc. Main Business Overview
13.5.5 Vivus, Inc. Latest Developments
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Teva Pharmaceutical Industries Ltd. Company Information
13.6.2 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product Offered
13.6.3 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.7 SK Chemicals
13.7.1 SK Chemicals Company Information
13.7.2 SK Chemicals Erectile Dysfunction Medicine Product Offered
13.7.3 SK Chemicals Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 SK Chemicals Main Business Overview
13.7.5 SK Chemicals Latest Developments
13.8 Meda Pharmaceuticals, Inc.
13.8.1 Meda Pharmaceuticals, Inc. Company Information
13.8.2 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product Offered
13.8.3 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Meda Pharmaceuticals, Inc. Main Business Overview
13.8.5 Meda Pharmaceuticals, Inc. Latest Developments
13.9 Cristalia Produtos Quimicos Farmaceuticos Ltda
13.9.1 Cristalia Produtos Quimicos Farmaceuticos Ltda Company Information
13.9.2 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product Offered
13.9.3 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cristalia Produtos Quimicos Farmaceuticos Ltda Main Business Overview
13.9.5 Cristalia Produtos Quimicos Farmaceuticos Ltda Latest Developments
13.10 Apricus Biosciences, Inc.
13.10.1 Apricus Biosciences, Inc. Company Information
13.10.2 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product Offered
13.10.3 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apricus Biosciences, Inc. Main Business Overview
13.10.5 Apricus Biosciences, Inc. Latest Developments
13.11 Futura Medical plc.
13.11.1 Futura Medical plc. Company Information
13.11.2 Futura Medical plc. Erectile Dysfunction Medicine Product Offered
13.11.3 Futura Medical plc. Erectile Dysfunction Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Futura Medical plc. Main Business Overview
13.11.5 Futura Medical plc. Latest Developments
14 Research Findings and Conclusion
Table 1. Erectile Dysfunction Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Erectile Dysfunction Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Viagra
Table 4. Major Players of Cialis
Table 5. Major Players of Levitra
Table 6. Major Players of Stendra
Table 7. Global Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 8. Global Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
Table 9. Global Erectile Dysfunction Medicine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2022)
Table 11. Global Erectile Dysfunction Medicine Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 13. Global Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Table 14. Global Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022)
Table 15. Global Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2022)
Table 16. Global Erectile Dysfunction Medicine Sale Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 17. Global Erectile Dysfunction Medicine Sales by Company (2020-2022) & (K Units)
Table 18. Global Erectile Dysfunction Medicine Sales Market Share by Company (2020-2022)
Table 19. Global Erectile Dysfunction Medicine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Erectile Dysfunction Medicine Revenue Market Share by Company (2020-2022)
Table 21. Global Erectile Dysfunction Medicine Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Erectile Dysfunction Medicine Producing Area Distribution and Sales Area
Table 23. Players Erectile Dysfunction Medicine Products Offered
Table 24. Erectile Dysfunction Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Erectile Dysfunction Medicine Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Erectile Dysfunction Medicine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Erectile Dysfunction Medicine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Erectile Dysfunction Medicine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Erectile Dysfunction Medicine Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Erectile Dysfunction Medicine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Erectile Dysfunction Medicine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Erectile Dysfunction Medicine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 36. Americas Erectile Dysfunction Medicine Sales Market Share by Country (2017-2022)
Table 37. Americas Erectile Dysfunction Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Erectile Dysfunction Medicine Revenue Market Share by Country (2017-2022)
Table 39. Americas Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 40. Americas Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
Table 41. Americas Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 42. Americas Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Table 43. APAC Erectile Dysfunction Medicine Sales by Region (2017-2022) & (K Units)
Table 44. APAC Erectile Dysfunction Medicine Sales Market Share by Region (2017-2022)
Table 45. APAC Erectile Dysfunction Medicine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Erectile Dysfunction Medicine Revenue Market Share by Region (2017-2022)
Table 47. APAC Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 48. APAC Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
Table 49. APAC Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 50. APAC Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Table 51. Europe Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 52. Europe Erectile Dysfunction Medicine Sales Market Share by Country (2017-2022)
Table 53. Europe Erectile Dysfunction Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Erectile Dysfunction Medicine Revenue Market Share by Country (2017-2022)
Table 55. Europe Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 56. Europe Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
Table 57. Europe Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 58. Europe Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Table 59. Middle East & Africa Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Erectile Dysfunction Medicine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Erectile Dysfunction Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Erectile Dysfunction Medicine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Erectile Dysfunction Medicine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 66. Middle East & Africa Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Erectile Dysfunction Medicine
Table 68. Key Market Challenges & Risks of Erectile Dysfunction Medicine
Table 69. Key Industry Trends of Erectile Dysfunction Medicine
Table 70. Erectile Dysfunction Medicine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Erectile Dysfunction Medicine Distributors List
Table 73. Erectile Dysfunction Medicine Customer List
Table 74. Global Erectile Dysfunction Medicine Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Erectile Dysfunction Medicine Sales Market Forecast by Region
Table 76. Global Erectile Dysfunction Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Erectile Dysfunction Medicine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Erectile Dysfunction Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Erectile Dysfunction Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Erectile Dysfunction Medicine Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Erectile Dysfunction Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Erectile Dysfunction Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Erectile Dysfunction Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Erectile Dysfunction Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Erectile Dysfunction Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Erectile Dysfunction Medicine Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Erectile Dysfunction Medicine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Erectile Dysfunction Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Erectile Dysfunction Medicine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Erectile Dysfunction Medicine Sales Forecast by Distribution Channel (2023-2028) & (K Units)
Table 91. Global Erectile Dysfunction Medicine Sales Market Share Forecast by Distribution Channel (2023-2028)
Table 92. Global Erectile Dysfunction Medicine Revenue Forecast by Distribution Channel (2023-2028) & ($ Millions)
Table 93. Global Erectile Dysfunction Medicine Revenue Market Share Forecast by Distribution Channel (2023-2028)
Table 94. Pfizer, Inc. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer, Inc. Erectile Dysfunction Medicine Product Offered
Table 96. Pfizer, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Pfizer, Inc. Main Business
Table 98. Pfizer, Inc. Latest Developments
Table 99. Dong-A ST Co., Ltd. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product Offered
Table 101. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Dong-A ST Co., Ltd. Main Business
Table 103. Dong-A ST Co., Ltd. Latest Developments
Table 104. Eli Lilly and Company Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Erectile Dysfunction Medicine Product Offered
Table 106. Eli Lilly and Company Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Bayer AG Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer AG Erectile Dysfunction Medicine Product Offered
Table 111. Bayer AG Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Bayer AG Main Business
Table 113. Bayer AG Latest Developments
Table 114. Vivus, Inc. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. Vivus, Inc. Erectile Dysfunction Medicine Product Offered
Table 116. Vivus, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Vivus, Inc. Main Business
Table 118. Vivus, Inc. Latest Developments
Table 119. Teva Pharmaceutical Industries Ltd. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product Offered
Table 121. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Teva Pharmaceutical Industries Ltd. Main Business
Table 123. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 124. SK Chemicals Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. SK Chemicals Erectile Dysfunction Medicine Product Offered
Table 126. SK Chemicals Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. SK Chemicals Main Business
Table 128. SK Chemicals Latest Developments
Table 129. Meda Pharmaceuticals, Inc. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product Offered
Table 131. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Meda Pharmaceuticals, Inc. Main Business
Table 133. Meda Pharmaceuticals, Inc. Latest Developments
Table 134. Cristalia Produtos Quimicos Farmaceuticos Ltda Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 135. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product Offered
Table 136. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Cristalia Produtos Quimicos Farmaceuticos Ltda Main Business
Table 138. Cristalia Produtos Quimicos Farmaceuticos Ltda Latest Developments
Table 139. Apricus Biosciences, Inc. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 140. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product Offered
Table 141. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Apricus Biosciences, Inc. Main Business
Table 143. Apricus Biosciences, Inc. Latest Developments
Table 144. Futura Medical plc. Basic Information, Erectile Dysfunction Medicine Manufacturing Base, Sales Area and Its Competitors
Table 145. Futura Medical plc. Erectile Dysfunction Medicine Product Offered
Table 146. Futura Medical plc. Erectile Dysfunction Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Futura Medical plc. Main Business
Table 148. Futura Medical plc. Latest Developments
List of Figures
Figure 1. Picture of Erectile Dysfunction Medicine
Figure 2. Erectile Dysfunction Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Erectile Dysfunction Medicine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Erectile Dysfunction Medicine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Erectile Dysfunction Medicine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Viagra
Figure 10. Product Picture of Cialis
Figure 11. Product Picture of Levitra
Figure 12. Product Picture of Stendra
Figure 13. Global Erectile Dysfunction Medicine Sales Market Share by Type in 2021
Figure 14. Global Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2022)
Figure 15. Erectile Dysfunction Medicine Consumed in Online Pharmacies
Figure 16. Global Erectile Dysfunction Medicine Market: Online Pharmacies (2017-2022) & (K Units)
Figure 17. Erectile Dysfunction Medicine Consumed in Retail Pharmacies
Figure 18. Global Erectile Dysfunction Medicine Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 19. Erectile Dysfunction Medicine Consumed in Hospital
Figure 20. Global Erectile Dysfunction Medicine Market: Hospital (2017-2022) & (K Units)
Figure 21. Global Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2022)
Figure 22. Global Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel in 2021
Figure 23. Erectile Dysfunction Medicine Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Erectile Dysfunction Medicine Revenue Market Share by Company in 2021
Figure 25. Global Erectile Dysfunction Medicine Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Erectile Dysfunction Medicine Revenue Market Share by Geographic Region in 2021
Figure 27. Global Erectile Dysfunction Medicine Sales Market Share by Region (2017-2022)
Figure 28. Global Erectile Dysfunction Medicine Revenue Market Share by Country/Region in 2021
Figure 29. Americas Erectile Dysfunction Medicine Sales 2017-2022 (K Units)
Figure 30. Americas Erectile Dysfunction Medicine Revenue 2017-2022 ($ Millions)
Figure 31. APAC Erectile Dysfunction Medicine Sales 2017-2022 (K Units)
Figure 32. APAC Erectile Dysfunction Medicine Revenue 2017-2022 ($ Millions)
Figure 33. Europe Erectile Dysfunction Medicine Sales 2017-2022 (K Units)
Figure 34. Europe Erectile Dysfunction Medicine Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Erectile Dysfunction Medicine Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Erectile Dysfunction Medicine Revenue 2017-2022 ($ Millions)
Figure 37. Americas Erectile Dysfunction Medicine Sales Market Share by Country in 2021
Figure 38. Americas Erectile Dysfunction Medicine Revenue Market Share by Country in 2021
Figure 39. United States Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Erectile Dysfunction Medicine Sales Market Share by Region in 2021
Figure 44. APAC Erectile Dysfunction Medicine Revenue Market Share by Regions in 2021
Figure 45. China Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Erectile Dysfunction Medicine Sales Market Share by Country in 2021
Figure 52. Europe Erectile Dysfunction Medicine Revenue Market Share by Country in 2021
Figure 53. Germany Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Erectile Dysfunction Medicine Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Erectile Dysfunction Medicine Revenue Market Share by Country in 2021
Figure 60. Egypt Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Erectile Dysfunction Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Erectile Dysfunction Medicine in 2021
Figure 66. Manufacturing Process Analysis of Erectile Dysfunction Medicine
Figure 67. Industry Chain Structure of Erectile Dysfunction Medicine
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...